TrialJAMA2001

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

What the trial testedas reported · 1,702 people · 2001

No range given

−14.7percentage points

As reported

difference −14.7 %, no interval

the abstract, start to end

… pravastatin reduced median CRP levels by 16.9% (P<.001) at 24 weeks, …

… reduction in CRP with pravastatin, 14.7%; P<.001) and was present among …

← favours treatmentfavours comparator →

could be chance

No interval given · direction only, strength unknown

Inflammation & biomarkers

−16.9

Body weight & composition

−14.7

StatinsBody weight & compositionInflammation & biomarkers

1 / 4

2001

…

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled ittrialcites it